Vardenafil Completed Phase 3 Trials for Pulmonary Hypertension (PH) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00718952The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension